<h2 id="Headline">
 Headline
</h2>
<h3 id="ZTGC__bacteriophages_reinvent_the_DNA_alphabet">
 ZTGC: bacteriophages reinvent the DNA alphabet
</h3>
<p>
 In 1977,
 <a href="https://pubmed.ncbi.nlm.nih.gov/413053">
  Kirnos et al.
 </a>
 isolated a DNA virus acting on blue-green algae, called cyanophage S-2L, from water samples taken in the outskirts of Leningrad (known today as
 <a href="https://en.wikipedia.org/wiki/Saint%5FPetersburg">
  Saint Petersburg
 </a>
 ). They reported a weird DNA composition for this virus. Instead of the usual adenine (6-aminopurine or A), the bacteriophage contained
 <a href="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:40235">
  2,6-diaminopurine
 </a>
 (DAP), also known as 2-aminoadenine, abbreviated Z in recent publications. The presence of the additional amino group in adenine
 <a href="https://pubmed.ncbi.nlm.nih.gov/30795872/">
  changes several DNA features
 </a>
 . The most striking difference is that DAP forms 3 hydrogen bonds when paired with thymine, instead of the usual 2 bonds between adenine and thymine, hence forming a stronger, more stable pair. The presence of DAP confers selective advantages to bacteriophages, such as
 <a href="https://pubmed.ncbi.nlm.nih.gov/2820801,2829119,33926954/">
  resistance to most restriction enzymes
 </a>
 . Consequently, these viruses can evade the host bacterial defense system based on foreign DNA degradation.
</p>
<p>
 In view of the complete substitution of adenine by DAP,
 <a href="https://pubmed.ncbi.nlm.nih.gov/413053">
  Kirnos et al.
 </a>
 proposed that DAP was incorporated into S-2L phage DNA as a ready-made nucleotide, rather than formed at the polynucleotide level as a result of amination of adenine residues within DNA. However, it took almost half a century to
 <a href="https://www.ncbi.nlm.nih.gov/pubmed/33926954,33926955,33926956,33893297">
  unravel the pathway of DAP synthesis and its incorporation into DNA
 </a>
 . This pathway intermingles viral and bacterial enzymes in tight collaboration. The first step of DAP synthesis involves the condensation of aspartate with deoxyguanylate to form N6-succino-2-amino-2'-deoxyadenylate (
 <a href="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:172924">
  dSMP
 </a>
 ). The reaction is catalyzed by phage PurZ. dSMP is then converted into 2-amino-2'-deoxyadenosine monophosphate (
 <a href="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:172927">
  dZMP
 </a>
 ) by an enzyme encoded by
 <em>
  purB
 </em>
 . dZMP is further phosphorylated by guanylate kinase (
 <em>
  gmk
 </em>
 ) and by nucleoside diphosphate kinase (
 <em>
  ndk
 </em>
 ) to produce 2-amino-2'-deoxyadenosine-5'-triphosphate (
 <a href="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:172931">
  dZTP
 </a>
 ). All three enzymes, encoded by the
 <em>
  purB
 </em>
 ,
 <em>
  gmk
 </em>
 and
 <em>
  ndk
 </em>
 genes, are provided by the bacterial host. dZTP is incorporated into phage DNA by viral DpoZ polymerase, which shares similarity with the Klenow fragment of
 <em>
  Escherichia coli
 </em>
 DNA polymerase I. The selective incorporation of dZTP rather than dATP into phage DNA is still a matter of debate.
 <a href="https://pubmed.ncbi.nlm.nih.gov/33926956/">
  Pezo et al.
 </a>
 showed that DpoZ has a strong preference for dZTP over dATP. However,
 <a href="https://pubmed.ncbi.nlm.nih.gov/33893297,33926954">
  Czernecki and Zhou
 </a>
 proposed another mechanism of dATP exclusion, in which another phage enzyme, a dATPase called DatZ, would break up dATP, while preserving dZTP. The removal of dATP (and of its precursor dADP) from the nucleotide pool of the host would prevent the incorporation of adenine into the phage genome.
</p>
<p>
 If cyanophage S-2L looked like a strange outlier 50 years ago, nowadays its amazing DNA composition appears to be more widespread than anticipated. PurZ has been identified in over a hundred bacteriophages, that infect a variety of microorganisms, including cyanobacteria, proteobacteria and actinobacteria, and the presence of Z-genomes have been experimentally proven in several of them. DAP usage to convey genetic information may be ancient. Phylogenic trees of PurZ and DpoZ indicate that DAP may have been used among siphoviruses since the
 <a href="https://pubmed.ncbi.nlm.nih.gov/33926956/">
  evolutionary divergence of actinobacteria, cyanobacteria, and proteobacteria some 3.5 billion years ago
 </a>
 . Moreover DAP, along with other nucleobases,
 <a href="https://pubmed.ncbi.nlm.nih.gov/21836052/">
  has been found in meteorites
 </a>
 , suggesting it could have been available before the advent of life for constructing the first genetic molecules.
</p>
<p>
 As of this release, representative entries for the proteins involved in viral Z-genome manufacturing have been manually annotated and are publicly available. These entries include viral
 <a href="http://www.uniprot.org/uniprot/?query=accession:G3FFN6+or+accession:A0A7U3TBV6+or+accession:A0A2L0V130+or+accession:A0A2H5BHJ6">
  PurZ
 </a>
 , DNA polymerase
 <a href="http://www.uniprot.org/uniprot/?query=accession:A0A2H5BHJ5+or+accession:A0A2L0V166+or+accession:G3FFN8">
  DpoZ
 </a>
 and dATPase
 <a href="http://www.uniprot.org/uniprot/?query=accession:A0A7U3TCA2+or+accession:A0A2H5BHG9+or+accession:A0A2L0V156+or+accession:G3FFN4">
  DatZ
 </a>
 and bacterial
 <a href="http://www.uniprot.org/uniprot/?query=accession:A0A0H3AL67+or+accession:P0AB89">
  PurB
 </a>
 ,
 <a href="http://www.uniprot.org/uniprot/?query=accession:Q3AWM1+or+accession:Q7U570+or+accession:Q9KNM4+or+accession:Q5N570+or+accession:Q0I868+or+accession:Q3ALX6+or+accession:Q2JQ59+or+accession:Q8KPQ7+or+accession:Q57I92+or+accession:Q2JQB9">
  Gmk
 </a>
 and
 <a href="http://www.uniprot.org/uniprot/?query=accession:Q57LI3+or+accession:A5F3F7+or+accession:Q3AGP0+or+accession:B2I3E1+or+accession:B0V4U1+or+accession:B1XIE7+or+accession:Q5N1M1+or+accession:B7H073+or+accession:Q9KTX4+or+accession:C0PYM7+or+accession:Q7U3S1+or+accession:B0VKS3+or+accession:Q3AVV5+or+accession:Q2JVI1+or+accession:B7I5G3+or+accession:C3LT09+or+accession:P50590+or+accession:Q0I6J3+or+accession:A5GPE9+or+accession:A3M207+or+accession:Q2JPL4">
  Ndk
 </a>
 . Viral PurZ proteins can also be identified with
 <a href="https://hamap.expasy.org/signature/MF%5F04166">
  a newly created HAMAP family profile
 </a>
 .
</p>
<p>
 It should be noted that DAP has been first abbreviated 'D', but more recently the abbreviation 'Z' took over and DNA containing this nucleotide was called 'Z-DNA'. This latter nomenclature may be
 <a href="https://pubmed.ncbi.nlm.nih.gov/34131341/">
  misleading
 </a>
 . The term 'Z-DNA' classically refers to a specific
 <a href="https://en.wikipedia.org/wiki/Z-DNA">
  left-handed double helical structure in which the helix winds to the left in a zigzag pattern, instead of to the right, like the more common B-DNA form
 </a>
 . This type of structure does not contain 2,6-diaminopurine.
</p>
<h2 id="UniProtKB_news">
 UniProtKB news
</h2>
<h3 id="Changes_to_the__a_href___docs_humdisease__controlled_vocabulary_of_human_diseases__a_">
 Changes to the
 <a href="http://www.uniprot.org/docs/humdisease">
  controlled vocabulary of human diseases
 </a>
</h3>
<p>
 New diseases:
</p>
<ul>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06078">
   Alzahrani-Kuwahara syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06114">
   Arthrogryposis multiplex congenita 6
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06054">
   Azoospermia, obstructive, with nephrolithiasis
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06071">
   Baralle-Macken syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06116">
   Bartsocas-Papas syndrome 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06059">
   Bile acid conjugation defect 1
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06077">
   Bleeding disorder, platelet-type, 24
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06094">
   Blepharophimosis-impaired intellectual development syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06101">
   Buratti-Harel syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06115">
   Cataracts, spastic paraparesis, and speech delay
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06109">
   Coffin-Siris syndrome 12
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06118">
   Dysostosis multiplex, Ain-Naz type
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06081">
   CIMDAG syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06082">
   Deafness, autosomal dominant, 80
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06102">
   Developmental and epileptic encephalopathy 6B
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06117">
   Developmental and epileptic encephalopathy 96
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06057">
   Developmental delay with dysmorphic facies and dental anomalies
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06091">
   Dystonia 30
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06112">
   Fibromuscular dysplasia, multifocal
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06076">
   Glanzmann thrombasthenia 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06063">
   Global developmental delay with speech and behavioral abnormalities
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06106">
   Growth restriction, hypoplastic kidneys, alopecia, and distinctive facies
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06098">
   Hiatt-Neu-Cooper neurodevelopmental syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06067">
   Hypercholanemia, familial, 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06085">
   Immunodeficiency 14B, autosomal recessive
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06056">
   Immunodeficiency 77
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06055">
   Immunodeficiency 78 with autoimmunity and developmental delay
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06061">
   Immunodeficiency 79
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06100">
   Immunodeficiency 80 with or without congenital cardiomyopathy
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06105">
   Intellectual developmental disorder, autosomal dominant 65
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06110">
   Intellectual developmental disorder and hypogonadotropic hypogonadism
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06066">
   Juberg-Hayward syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06095">
   KINSSHIP syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06058">
   Kohlschutter-Tonz syndrome-like
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06097">
   Leukodystrophy, hypomyelinating, 21
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06111">
   Leukodystrophy, hypomyelinating, 22
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06104">
   Lymphatic malformation 9
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06086">
   Mahvash disease
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06107">
   Marbach-Rustad progeroid syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06120">
   Megacystis-microcolon-intestinal hypoperistalsis syndrome 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06089">
   Megaloblastic anemia, folate-responsive
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06083">
   Microcephaly, epilepsy, and diabetes syndrome 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06080">
   Mitochondrial complex I deficiency, nuclear type 37
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06075">
   Nephrotic syndrome 24
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06073">
   Neurodegeneration with ataxia and late-onset optic atrophy
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06068">
   Neurodevelopmental disorder with cerebral atrophy and variable facial dysmorphism
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06113">
   Neurodevelopmental disorder with cerebellar atrophy and motor dysfunction
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06096">
   Neurodevelopmental disorder with dysmorphic facies and cerebellar hypoplasia
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06069">
   Neurodevelopmental disorder with dysmorphic facies and variable seizures
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06062">
   Neurodevelopmental disorder with or without autism or seizures
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06108">
   Neurodevelopmental disorder with seizures and gingival overgrowth
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06070">
   Neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06103">
   Oculogastrointestinal neurodevelopmental syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06079">
   Ondontochondrodysplasia 2 with hearing loss and diabetes
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06084">
   Parkinsonism with polyneuropathy
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06087">
   Pontocerebellar hypoplasia 14
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06088">
   Pontocerebellar hypoplasia 15
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06092">
   Pontocerebellar hypoplasia 1E
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06093">
   Pontocerebellar hypoplasia 1F
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06064">
   Premature ovarian failure 19
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06099">
   Radio-Tartaglia syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06090">
   Roifman-Chitayat syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06060">
   Short stature, oligodontia, dysmorphic facies, and motor delay
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06072">
   Spermatogenic failure 53
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06074">
   Spondyloepiphyseal dysplasia, sensorineural hearing loss, impaired intellectual development, and Leber congenital amaurosis
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06119">
   Visceral myopathy 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-06065">
   Vitreoretinopathy with phalangeal epiphyseal dysplasia
  </a>
 </li>
</ul>
<p>
 Modified diseases:
</p>
<ul>
 <li>
  Bleeding disorder, platelet-type 8 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02867">
   Bleeding disorder, platelet-type, 8
  </a>
 </li>
 <li>
  Bleeding disorder, platelet-type 11 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03257">
   Bleeding disorder, platelet-type, 11
  </a>
 </li>
 <li>
  Bleeding disorder, platelet-type 13 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03258">
   Bleeding disorder, platelet-type, 13
  </a>
 </li>
 <li>
  Bleeding disorder, platelet-type 16 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03752">
   Bleeding disorder, platelet-type, 16
  </a>
 </li>
 <li>
  Bleeding disorder, platelet-type 15 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03753">
   Bleeding disorder, platelet-type, 15
  </a>
 </li>
 <li>
  Bleeding disorder, platelet-type 17 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04008">
   Bleeding disorder, platelet-type, 17
  </a>
 </li>
 <li>
  Bleeding disorder, platelet-type 18 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04150">
   Bleeding disorder, platelet-type, 18
  </a>
 </li>
 <li>
  Bleeding disorder, platelet-type 19 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04294">
   Bleeding disorder, platelet-type, 19
  </a>
 </li>
 <li>
  Bleeding disorder, platelet-type 20 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04706">
   Bleeding disorder, platelet-type, 20
  </a>
 </li>
 <li>
  Bleeding disorder, platelet-type 21 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04984">
   Bleeding disorder, platelet-type, 21
  </a>
 </li>
 <li>
  Bleeding disorder, platelet-type 22 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05589">
   Bleeding disorder, platelet-type, 22
  </a>
 </li>
</ul>
<h3 id="Changes_to_the__a_href___docs_ptmlist__controlled_vocabulary_for_PTMs__a_">
 Changes to the
 <a href="http://www.uniprot.org/docs/ptmlist">
  controlled vocabulary for PTMs
 </a>
</h3>
<p>
 New term for the feature key 'Cross-link' ('CROSSLNK' in the flat file):
</p>
<ul>
 <li>
  4-(1-hydroxyethyl)-7-isoleucino-2-(threonin-O3-ylcarbonyl)-7,8-dihydroquinolin-8-ol (Ile-Thr)
 </li>
</ul>
<p>
 New term for the feature key 'Lipidation' ('LIPID' in the flat file):
</p>
<ul>
 <li>
  Phosphatidylserine amidated glycine
 </li>
</ul>
<p>
 New terms for the feature key 'Modified residue' ('MOD_RES' in the flat file):
</p>
<ul>
 <li>
  5-glutamyl glycine
 </li>
 <li>
  ADP-alpha-D-ribosylarginine
 </li>
</ul>